WEST PHARMACEUTICAL SERVICES INC 8-K

What Happened

• West Pharmaceutical Services, Inc. announced its first-quarter 2026 results in a press release and investor presentation issued April 23, 2026. The company reported these results via an 8-K (Item 2.02) filed the same day. The report was signed by Robert W. McMahon, Senior VP and Chief Financial Officer.

Key Details

• Item 2.02: Company issued a press release reporting first-quarter 2026 financial results (Exhibit 99.1).
• Item 7.01: The filing includes Regulation FD disclosure (information provided in the filing).
• Item 9.01: Exhibits attached — press release (99.1) and investor presentation (99.2); cover page Inline XBRL (104).
• Filing date and attachments: April 23, 2026; signed by CFO Robert W. McMahon.

Why It Matters

• The 8-K notifies investors that West has publicly released its Q1 2026 earnings and supporting presentation — primary sources for updated revenue, earnings, and quarterly performance metrics. Investors should review the attached press release (Exhibit 99.1) and presentation (Exhibit 99.2) for detailed figures and management commentary to assess near-term results and outlook.